Laverock Therapeutics is expanding its therapeutic pipeline into in vivo [...]

Fractyl Health has reported positive one-year data from the midpoint [...]

Resalis Therapeutics has dosed the first participant in a Phase [...]

Confo Therapeutics has presented preclinical data supporting the development of [...]

Currax Pharmaceuticals is highlighting a peer-reviewed publication supporting the use [...]

European liver disease specialists have highlighted the growing burden of [...]

Scribe Therapeutics has achieved a second success milestone in its [...]

insitro has completed what it says is the first population-scale [...]

Skye Bioscience has reported topline results from its Phase 2a [...]

Analysis highlights potential for benefits far beyond obesity, signalling a [...]